Stay updated with breaking news from Nasdaq Imrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mizuho upgraded shares of Immuneering (NASDAQ:IMRX – Get Rating) from a neutral rating to a buy rating in a research note released on Wednesday, MarketBeat.com reports. The brokerage currently has $20.00 target price on the stock, up from their prior target price of $10.00. A number of other brokerages have also recently weighed in on […]
Mizuho upgraded shares of Immuneering (NASDAQ:IMRX – Get Rating) from a neutral rating to a buy rating in a research report released on Wednesday, Marketbeat Ratings reports. They currently have $20.00 price objective on the stock, up from their prior price objective of $10.00. IMRX has been the topic of several other research reports. Morgan […]
Morgan Stanley upgraded shares of Immuneering (NASDAQ:IMRX – Get Rating) from an underweight rating to an equal weight rating in a report issued on Wednesday morning, The Fly reports. The firm currently has $14.00 target price on the stock, up from their prior target price of $5.00. A number of other research firms have also […]
Mizuho assumed coverage on shares of Immuneering (NASDAQ:IMRX – Get Rating) in a report released on Wednesday morning, The Fly reports. The brokerage issued a neutral rating and a $10.00 price objective on the stock. Several other equities analysts have also commented on the company. Chardan Capital reissued a buy rating and issued a $18.00 […]
Mizuho assumed coverage on shares of Immuneering (NASDAQ:IMRX – Get Rating) in a report released on Wednesday morning, The Fly reports. The brokerage issued a neutral rating and a $10.00 price objective on the stock. Several other equities analysts have also commented on the company. Chardan Capital reissued a buy rating and issued a $18.00 […]